Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 4
1964 3
1965 4
1967 6
1968 3
1969 1
1970 2
1971 3
1972 3
1973 5
1974 2
1975 4
1976 4
1977 4
1978 7
1979 12
1980 6
1981 8
1982 12
1983 14
1984 12
1985 18
1986 19
1987 9
1988 9
1989 11
1990 13
1991 18
1992 10
1993 31
1994 33
1995 23
1996 34
1997 37
1998 29
1999 23
2000 24
2001 11
2002 11
2003 11
2004 9
2005 11
2006 7
2007 23
2008 14
2009 20
2010 20
2011 21
2012 35
2013 27
2014 26
2015 25
2016 19
2017 24
2018 20
2019 18
2020 29
2021 31
2022 32
2023 36
2024 35

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

916 results

Results by year

Filters applied: . Clear all
Page 1
Fabry disease.
Yuasa T, Takenaka T, Higuchi K, Uchiyama N, Horizoe Y, Cyaen H, Mizukami N, Takasaki K, Kisanuki A, Miyata M, Ohishi M. Yuasa T, et al. Among authors: takenaka t. J Echocardiogr. 2017 Dec;15(4):151-157. doi: 10.1007/s12574-017-0340-x. Epub 2017 Jul 3. J Echocardiogr. 2017. PMID: 28674962 Review.
Central blood pressure and chronic kidney disease.
Ohno Y, Kanno Y, Takenaka T. Ohno Y, et al. Among authors: takenaka t. World J Nephrol. 2016 Jan 6;5(1):90-100. doi: 10.5527/wjn.v5.i1.90. World J Nephrol. 2016. PMID: 26788468 Free PMC article. Review.
Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications.
Toyokawa G, Bersani F, Bironzo P, Picca F, Tabbò F, Haratake N, Takenaka T, Seto T, Yoshizumi T, Novello S, Scagliotti GV, Taulli R. Toyokawa G, et al. Among authors: takenaka t. Crit Rev Oncol Hematol. 2023 Apr;184:103966. doi: 10.1016/j.critrevonc.2023.103966. Epub 2023 Mar 15. Crit Rev Oncol Hematol. 2023. PMID: 36925092 Free article. Review.
Classical vs reverse pharmacology in drug discovery.
Takenaka T. Takenaka T. BJU Int. 2001 Sep;88 Suppl 2:7-10; discussion 49-50. doi: 10.1111/j.1464-410x.2001.00112.x. BJU Int. 2001. PMID: 11589663 Review. No abstract available.
Sodium and kidney disease.
Suzuki H, Takenaka T, Kanno Y, Ohno Y, Saruta T. Suzuki H, et al. Among authors: takenaka t. Contrib Nephrol. 2007;155:90-101. doi: 10.1159/000101002. Contrib Nephrol. 2007. PMID: 17369717 Review.
Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients.
Oku Y, Toyokawa G, Wakasu S, Kinoshita F, Takamori S, Watanabe K, Haratake N, Nagano T, Kosai K, Takada K, Fujimoto A, Higashijima K, Shiraishi Y, Tanaka K, Takeoka H, Okamoto M, Yamashita T, Shimokawa M, Shoji F, Yamazaki K, Okamoto T, Seto T, Ueda H, Takeo S, Nakashima N, Okamoto I, Takenaka T, Yoshizumi T. Oku Y, et al. Among authors: takenaka t. Cancer Med. 2023 Jul;12(13):14327-14336. doi: 10.1002/cam4.6110. Epub 2023 May 21. Cancer Med. 2023. PMID: 37211905 Free PMC article.
916 results